Skip to main content

Table 3 Logistic regression model evaluating risk factors associated with 28-day mortality in severe patients with COVID-19 and HBV co-infection (on admission)

From: Corticosteroid treatment in severe patients with SARS-CoV-2 and chronic HBV co-infection: a retrospective multicenter study

Variables

28-day mortality

In-hospital mortality

Acute liver injury

Acute kidney injury

Acute cardiac injury

OR

95% CI

P value

OR

95% CI

P value

OR

95% CI

P value

OR

95% CI

P value

OR

95% CI

P value

Age

1.067

1.003–1.135

0.041

1.078

1.016–1.143

0.013

         

Gender (Male vs Female)

      

2.256

1.015–5.013

0.046

      

Comorbidity

            

4.737

1.264–17.745

0.021

Lymphocyte count < 0.8 × 109/L

5.933

1.440–24.450

0.014

            

d-dimer > 1 μg/mL

5.780

1.478–22.610

0.012

      

2.232

1.042–3.950

0.043

   

Albumin < 30 g/L

   

5.410

1.444–20.269

0.012

         

Corticosteroid treatment

6.318

1.166–34.239

0.033

11.743

2.299–59.992

0.003

         
  1. Comorbidity: Other underlying diseases excluding HBV infection; ALT: alanine amino transferase; Hs-CRP: High sensitive c reaction protein; OR: odds ratio; CI: confidence intervals
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us